What you need to know to understand Alexey Navalny, one of Vladimir Putin’s loudest critics
How some North Dakota farmers and two former Cheesecake Factory execs are reinventing casual dining
Campaigns to raise the minimum wage are finally coming to fruition
The Salesforce.com CEO is pushing his fellow tech billionaires into giving back to the city
From the U.S. jobless rate to the ruble to pollution in Beijing, here are 10 key indicators that you'll want to keep an eye on
Irate parents find an "extruding tool" for decorating cakes unsavory
Reward points suffer from inflation, too. Here are three strategies for getting the most out of the points you have, before their value falls
"No place to rage quite like the Kasper Multipurpose Room," one student gripes
The Zappos CEO is spending $350 million to build a startup paradise in downtown Las Vegas. It hasn't been all unicorns and butterflies
San Mateo, Calif.
Founders: Dr. Michael Selley, Dr. Lawrence Steinman, and Dr. Marc Feldmann
VC Investment over the last four quarters: $27 million
Founded in Australia in 2005 and established in the U.S. in 2007, Nuon Therapeutics is a clinical stage company developing oral treatments for multiple sclerosis and rheumatoid arthritis. The six-employee firm, which had previously raised a $5 million Series A round, is continuing development while conserving cash during the downturn, says CEO Rodney Pearlman. "Since we are in clinical stage development, this can be an expensive phase, so we have to ensure we meet our goals while being fiscally responsive to the current environment," he says.
Key to startup success: "Be opportunistic and think outside the box."